Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1, Randomized, Double-Blind, Multiple Dose, Multi-Center Study to Compare the Safety of ASP2151 to Valacylcovir and Placebo in Healthy Male and Female Subjects

NCT00870441 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT00870441
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00870441 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1, Randomized, Double-Blind, Multiple Dose, Multi-Center Study to Compare the Safety of ASP2151 to Valacylcovir and Placebo in Healthy Male and Female Subjects
Lead sponsor
Astellas Pharma Inc
Phase
Phase 1
Overall status
Terminated
Start date
March 31, 2009
Completion date
April 30, 2010
Enrollment
442 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

safety of asp2151